Responsibilities Provide WW Medical Affairs therapeutic area expertise and scientific leadership for CAR T compounds in clinical development. Lead cross‑functional strategy for Multiple Myeloma and/or Solid Tumor pipeline assets; align with local medical affairs teams. Develop medical strategy for cell therapy entry into Solid Tumor and provide input to early asset portfolio. Drive cross‑asset collaboration/knowledge sharing across Cell Therapy and Oncology; build thought‑leader relationships. Execute medical affairs deliverables: medical plan, publication planning/review, congress strategies, BMS symposia (e.g., COMy/EHA/IMS), refine Integrated Evidence Plan (IEP), update launch materials. Lead/support global advisory boards and committee meetings; provide evidence‑generation perspective (ISR/CRC trials, HEOR). Provide cross‑matrix scientific/medical expertise for early and late development; advise on asset/portfolio decisions (MM) and early solid tumor assets (starting with RCC); support market access/marketing content and patient advocacy engagement. Qualifications & Skills MD/PhD/PharmD with clinical and/or 6–8 years Pharma industry experience; Medical Affairs or related experience required. CAR‑T and Multiple Myeloma knowledge preferred. Familiarity with clinical/translational research. Strong communication, prioritization, strategic thinking, leadership, and cross‑functional collaboration. Estimated 15–20% US and global travel. Benefits (explicit) Health coverage (medical/pharmacy/dental/vision), wellbeing support, and 401(k) plus life/disability/insurance; Paid Time Off. Compensation Princeton, NJ (US): $207,490–$251,433. #J-18808-Ljbffr